SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001354488-13-001917
Filing Date
2013-04-12
Accepted
2013-04-12 15:38:50
Documents
3
Period of Report
2011-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT tbuff_8ka.htm 8-K/A 148605
2 EXECUTIVE EMPLOYMENT AGREEMENT tbuff_ex101.htm EX-1.1 216826
3 EXECUTIVE EMPLOYMENT AGREEMENT tbuff_ex102.htm EX-10.2 219250
  Complete submission text file 0001354488-13-001917.txt   586437
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 13758666
SIC: 2834 Pharmaceutical Preparations